Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lyra Therapeutics

0.0982
+0.00384.03%
Post-market: 0.0950-0.0032-3.26%19:59 EDT
Volume:1.23M
Turnover:119.77K
Market Cap:6.51M
PE:-0.08
High:0.1014
Open:0.0965
Low:0.0944
Close:0.0944
Loading ...
Apr 13, 2021

Major Issues Report

8-K - Current report
Mar 09, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 30, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 10, 2020

Major Issues Report

8-K/A [Amend] - Current report
Dec 07, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2020

Major Issues Report

8-K - Current report
Oct 30, 2020

Major Issues Report

8-K - Current report
Aug 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2020

Major Issues Report

8-K - Current report
Jul 24, 2020

Major Issues Report

8-K - Current report
Jun 01, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
May 28, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 28, 2020

Major Issues Report

8-K - Current report